Neville Rodie & Shaw’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-23,147
| Closed | -$183K | – | 247 |
|
2024
Q2 | $183K | Hold |
23,147
| – | – | 0.01% | 237 |
|
2024
Q1 | $314K | Hold |
23,147
| – | – | 0.02% | 215 |
|
2023
Q4 | $250K | Hold |
23,147
| – | – | 0.02% | 226 |
|
2023
Q3 | $150K | Hold |
23,147
| – | – | 0.01% | 241 |
|
2023
Q2 | $417K | Sell |
23,147
-11,923
| -34% | -$215K | 0.04% | 196 |
|
2023
Q1 | $824K | Hold |
35,070
| – | – | 0.07% | 140 |
|
2022
Q4 | $877K | Hold |
35,070
| – | – | 0.08% | 136 |
|
2022
Q3 | $1.12M | Hold |
35,070
| – | – | 0.11% | 115 |
|
2022
Q2 | $1.39M | Buy |
35,070
+34,720
| +9,920% | +$1.37M | 0.12% | 106 |
|
2022
Q1 | $14K | Hold |
350
| – | – | ﹤0.01% | 261 |
|
2021
Q4 | $18K | Hold |
350
| – | – | ﹤0.01% | 264 |
|
2021
Q3 | $23K | Hold |
350
| – | – | ﹤0.01% | 258 |
|
2021
Q2 | $14K | Hold |
350
| – | – | ﹤0.01% | 261 |
|
2021
Q1 | $18K | Hold |
350
| – | – | ﹤0.01% | 257 |
|
2020
Q4 | $24K | Hold |
350
| – | – | ﹤0.01% | 255 |
|
2020
Q3 | $13K | Hold |
350
| – | – | ﹤0.01% | 245 |
|
2020
Q2 | $14K | Hold |
350
| – | – | ﹤0.01% | 243 |
|
2020
Q1 | $11K | Hold |
350
| – | – | ﹤0.01% | 226 |
|
2019
Q4 | $40K | Hold |
350
| – | – | ﹤0.01% | 247 |
|
2019
Q3 | $11K | Hold |
350
| – | – | ﹤0.01% | 241 |
|
2019
Q2 | $15K | Hold |
350
| – | – | ﹤0.01% | 244 |
|
2019
Q1 | $19K | Hold |
350
| – | – | ﹤0.01% | 249 |
|
2018
Q4 | $10K | Hold |
350
| – | – | ﹤0.01% | 233 |
|
2018
Q3 | $16K | Hold |
350
| – | – | ﹤0.01% | 252 |
|
2018
Q2 | $8K | Buy |
+350
| New | +$8K | ﹤0.01% | 257 |
|